US FDA approves Novartis’ gene therapy for rare muscle disorder
The U.S. Food and Drug Administration has approved Novartis’ gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday. The therapy, branded as Itvisma, was approved…
Eris Lifesciences to pick up remining 30% in Swiss Parenterals for ₹423 crore
In a development that comes more than a year after it picked up stake in Swiss Parenterals, the board of Eris Lifesciences approved the latest transaction that will be will…
Dr Reddy’s gets EC nod for AVT03: New Prolia and Xgeva biosimilar set to launch across Europe
Dr Reddy’s Laboratories has received marketing approval from the European Commission (EC) for AVT03, a biosimilar of Prolia (denosumab) and Xgeva (denosumab) prescribed in the treatment of bone related conditions,…
Tg launches 1 Bio, single-use biopharma scale-up hub
The IT Minister announced over `200 crore in new infrastructure upgrades by TGIIC Hyderabad: In a major boost to India’s biologics and next-generation therapeutics ecosystem, Telangana, on Monday inaugurated 1…
Indore SEZ exports jump 32 pc due to increased orders from pharma units
Exports from Indore’s Special Economic Zone (SEZ) jumped 32 percent to Rs 8,127.67 crore during the first seven months of the current financial year due to increased orders from pharmaceutical…
Eli Lilly becomes first pharma major to enter $1 trillion M-Cap club; stock price rises 1.7% on Wall St.
United States-based drugmaker Eli Lilly on 21 November 2025, became the first pharmaceutical company and only the second non-technology firm, to enter the trillion-dollar market capitalisation club after its stock…
MNC drugmakers push for 10-yr exclusivity for trial data
The Organisation of Pharmaceutical Producers of India (OPPI), which represents research-based global pharmaceutical companies in the country, is seeking an exclusivity period of 10 years after market authorisation for protection…
Curbs on risky drugs online ads
While there is no official data to show a surge in drug advertising, the government gets such inputs via complaints based on regulatory intelligence and monitoring, the official cited earlier…
BE’s new vaccine for pneumonia gets WHO approval
Biological E Limited (BE), the city-headquartered vaccine and pharmaceutical manufacturer, has said that its 14-valent pneumococcal conjugate vaccine, PNEUBEVAX 14, has been granted pre-qualification status by the World Health Organisation…
India’s Drug Regulator Finds 211 Medicines As Not Of Standard Quality In October
The drugs include Calcium and Vitamin D3, anti-worm medication, anti-bacterial medication, Paracetamol tablets among others. New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has identified as many as 211 drugs…
